All stock lists
Grupo Cibest S.A. (New York Stock Exchange:CIB)
CO · Delayed Price · Currency is USD
Financial Services · Banks - Regional
92.37+0.15 (+0.16%)
Market cap
$21.8B
Insider Score
Health Score
Analyst consensus
Listed since
Jul 26, 1995
Website
Insider Score
––Not scored
CIB Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Strong
From CIB’s reported statements · Q2 2026 (trailing 12 months)
Profitability19 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $44308.91B
- Net income
- $7708.04B
- Net margin
- 17.4%
Leverage20 / 20
Little or no net debt.
- Total debt
- $23715.03B
- Cash
- $26829.84B
- Net debt / EBITDA
- -0.27x
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $26829.84B
- Current liabilities
- $6454.60B
- Current ratio
- 4.16
Cash generation20 / 20
The business funds itself from operations.
- Operating cash flow
- $14035.36B
- Free cash flow
- $11692.88B
- FCF margin
- 26.4%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 236.2M
- Share growth (1y)
- -1.8%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
CIB Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 11498.82 B | 10463.11 B | 11689.17 B | 10657.80 B | 10529.45 B | 10286.64 B |
| Revenue Growth (YoY) | 9.21 % | 1.72 % | 6.19 % | -0.31 % | -2.19 % | -4.49 % |
| Cost of Revenue | 4070.92 B | 4273.33 B | 4758.59 B | 4142.83 B | 4451.10 B | 4452.98 B |
| Gross Profit | 7427.91 B | 6189.78 B | 6930.59 B | 6514.97 B | 6078.34 B | 5833.65 B |
| SG&A Expense | 1426.61 B | 2999.39 B | 1523.10 B | 2676.07 B | 3032.06 B | 2614.30 B |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 4023.37 B | 4044.42 B | 4938.00 B | 3515.89 B | 3594.35 B | 3369.97 B |
| Operating Income | 3404.54 B | 2145.36 B | 1992.58 B | 2999.08 B | 2484.00 B | 2463.69 B |
| Pretax Income | 3404.54 B | 2145.36 B | 1992.58 B | 2999.08 B | 2484.00 B | 2463.69 B |
| Tax Provision | 912.85 B | 709.54 B | 681.48 B | 842.75 B | 655.05 B | 698.91 B |
| Net Income | 2523.32 B | 1457.11 B | 1583.51 B | 2144.10 B | 1791.30 B | 1737.66 B |
| EPS (Basic) | 10672.24 | 6140.48 | 6641.52 | 8988.00 | 7449.60 | 7288.40 |
| EPS (Diluted) | 10672.24 | 6140.48 | 6641.52 | 8988.00 | 7449.60 | 7288.40 |
| Shares Outstanding | 236.16 M | 237.30 M | 238.30 M | 240.46 M | 240.46 M | 238.41 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.